Limiting reagents

4 July 2017 By John Foley

Hedge funds with a combined 7.2 percent stake in Swiss chemicals maker Clariant want to stop it merging with U.S. peer Huntsman. They have a good case – and the market had already marked the deal as a dud. It will be hard to salvage in a way that pleases investors on both sides.

This content is for Subscribers only

To access full content you must be a subscriber. Please use the following link to request a trial.


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)